Dr Mark Kris discusses how a small 2015 study with just two nivolumab doses led to a wave of curative-intent trials.

Ethicist Art Caplan discusses FDA layoffs and their impact on protection of human research subjects in clinical trials.

Older adults with apparent hypothyroidism may or may not need treatment. This second article about thyroid disease in older ...

Medication overuse is a major preventable driver of headache-related disability across the globe, highlighting the need for ...

A lower maintenance dose of peanut immunotherapy may provide similar effectiveness and an improved safety profile compared ...

Some primary care clinics are investing in social needs programs to overcome barriers to care. New evidence shows how these ...

A systematic review reports that monoclonal antibodies and JAK inhibitors can be effective in the treatment and clearance of ...

ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical ...

A personalised, moderately restricted low-protein diet is feasible in advanced CKD and is linked to a slower decline in ...

Video consultations do not significantly increase time in range over 1 year compared with standard in-person visits in ...

AI-based digital pathology revealed that efruxifermin had an additional impact on septa area as well as fibrosis in a post ...

Black or African American adults were diagnosed with diabetes 24% more frequently than the total population in 2024.